MedTrace Logo

Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake

NCT03141632 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2017-10-25

No results posted yet for this study

Summary

The aim of this study is to elucidate whether GLP-1 analogues influence not only appetite but also thirst perception. It is hypothesized that GLP-1 analogues reduce fluid intake in healthy volunteers compared to Placebo.

Conditions

  • Thirst
  • Water-Electrolyte Imbalance

Interventions

DRUG

Dulaglutide

Evaluation visit with assessment of fluid intake

OTHER

Placebo

Evaluation visit with assessment of fluid intake

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof · University Hospital fo Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-17
Primary Completion
2017-05-31
Completion
2017-05-12

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03141632 on ClinicalTrials.gov